Comparing different maintenance doses for wheat allergy oral immunotherapy
Part of Immune system & allergy clinical trials.
This study tests whether taking a maintenance dose of wheat oral immunotherapy once or twice a week is more effective for children with wheat allergy. It aims to find the best schedule to keep them protected from allergic reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 18 years old.
- You have a confirmed wheat allergy that involves IgE antibodies and was proven by a food challenge test.
- You have already reached the target maintenance dose of wheat oral immunotherapy and are still in that phase.
- You do not have poorly controlled eczema, asthma, or other chronic conditions.
- You have not used other allergy treatments like sublingual immunotherapy or biologic medications.
- You do not have a developmental or mental health disorder, active eosinophilic gut disease in the last 2 years, or use certain heart medications.
- You are not pregnant or breastfeeding, and you can attend clinic visits as scheduled.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (LP-003) to see if it can reduce allergic reactions to wheat or gluten. It might help people who currently experience symptoms like hives or stomach problems when they eat these foods.
This trial tests whether a controlled, gradual treatment called oral immunotherapy can help children with wheat allergy eat wheat safely. It involves a supervised wheat challenge first, then daily wheat doses for 12 months.
This study looks at whether children who have already completed an oral immunotherapy (desensitization) for sesame allergy can maintain protection after stopping the treatment. The goal is to see if they achieve 'sustained unresponsiveness,' meaning they can eat sesame without an allergic reaction.
This trial studies an oral immunotherapy approach, where children take tiny, controlled amounts of certain allergy-causing foods to build tolerance. It may help reduce allergic reactions, but only if kids meet safety and monitoring requirements.
This study compares two ways to manage food allergies in infants: giving tiny amounts of the allergen (oral immunotherapy) versus avoiding the allergen completely. It hopes to find out which approach helps young children outgrow their food allergies more effectively.
This study compares two ways of doing oral immunotherapy (gradually eating more of the allergen) for children with cow's milk or hen's egg allergy. It aims to find which method is safer and works better.
Hear when a new Immunotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.